Psychopharmacology Module 2

Continuing Education Eligibility (Included):

(BACB®) 2 Type II 
(QABA®) 2 General (In-person) 
APA: 2 General (Home Study)

Providers of Healthcare or education serving the needs of individuals with Autism or other special needs encounter medication related issues on a daily basis. Virtually every professional (and parents) understands that medication plays a significant factor in a person’s ability to function and make progress, but very few possess sufficient levels of knowledge to make informed decisions when providing services to children, adolescents and adults receiving medication. This lack of knowledge is even more pronounced when dealing with co-morbid conditions. 

SL Global’s Psychopharmacology series, with Dr. Ronald T. Brown and Dr. Debbie Coehlo is designed to provide educators, healthcare providers and parents with a comprehensive understanding of psychopharmacology and its impact on various childhood disorders.  

This series will start with a comprehensive overview of medication and childhood disorders. Subsequent modules will provide a deeper understanding of psychopharmacology as it pertains to specific conditions, including ADHD, Autism and other Mood Disorders. The series will conclude with sessions on Evidence-based practices, Ethics of Medication and a deeper look at assessing and diagnosing individuals with various conditions. 

Each 2-hour session will be broken down into three primary areas: (1) study on classes of medication; (2) how it relates to various symptoms; and (3) use of case studies to provide a deeper level of understanding by seeing how both come together in practice. 

Each LIVE Webinar will be 2 hours in length. Each LIVE Webinar will be broadcasted 12pm to 2pm Central.
 

This 7-part series includes these following titles:

Overview of Psychopharmacology and Childhood Disorders: March 10, 2021

Psychopharmacology and ADHD: April 14, 2021 

Psychopharmacology and Autism: May 12, 2021 

Psychopharmacology and Mood Disorders: June 9, 2021

Psychopharmacology and Evidence-Based Practices: July 14, 2021

Ethics of Medication: August 11, 2021

Psychopharmacology: Diagnosis and Assessment: September 8, 2021